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Abstract
Introduction: The mammary primordium forms during embryogenesis as a result of inductive interactions between its
constitutive tissues, the mesenchyme and epithelium, and represents the earliest evidence of commitment to the
mammary lineage. Previous studies of embryonic mouse mammary epithelium indicated that, by mid-gestation, these
cells are determined to a mammary cell fate and that a stem cell population has been delimited. Mammary
mesenchyme can induce mammary development from simple epithelium even across species and classes, and can
partially restore features of differentiated tissue to mouse mammary tumours in co-culture experiments. Despite these
exciting properties, the molecular identity of embryonic mammary cells remains to be fully characterised.
Methods: Here, we define the transcriptome of the mammary primordium and the two distinct cellular
compartments that comprise it, the mammary primordial bud epithelium and mammary mesenchyme. Pathway
and network analysis was performed and comparisons of embryonic mammary gene expression profiles to those
of both postnatal mouse and human mammary epithelial cell sub-populations and stroma were made.
Results: Several of the genes we have detected in our embryonic mammary cell signatures were previously shown
to regulate mammary cell fate and development, but we also identified a large number of novel candidates.
Additionally, we determined genes that were expressed by both embryonic and postnatal mammary cells, which
represent candidate regulators of mammary cell fate, differentiation and progenitor cell function that could signal
from mammary lineage inception during embryogenesis through postnatal development. Comparison of
embryonic mammary cell signatures with those of human breast cells identified potential regulators of mammary
progenitor cell functions conserved across species.
Conclusions: These results provide new insights into genetic regulatory mechanisms of mammary development,
particularly identification of novel potential regulators of mammary fate and mesenchymal-epithelial cross-talk. Since
cancers may represent diseases of mesenchymal-epithelial communications, we anticipate these results will provide
foundations for further studies into the fundamental links between developmental, stem cell and breast cancer biology.
Introduction
The mammary lineage is first established during organo-
genesis of the mammary primordium that forms during
embryogenesis. Mammary primordia, comprised of
mammary epithelial and associated mesenchymal tissues,
develop as a result of inductive crosstalk between the
surface epithelium and underlying mesenchyme [1].
During mouse embryogenesis, a multilayered epithelial
mammary placode is evident at embryonic day (E) 11.0,
which reaches the bud stage by E12.0. When E13.0
mammary primordial epithelium and salivary mesenchy-
mal tissue are co-cultured, they produce a ductal tree
that has morphological features of salivary ducts, but is
capable of secreting milk [2]. These results suggest that
by E13.0, mammary epithelium has been stably deter-
mined as mammary. Mammary mesenchyme can induce
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even from epithelium of other mammalian species and
across classes, suggesting that the inductive signals pro-
vided by the mammary mesenchyme and the responding
elements in the uninduced epithelium are highly con-
served during mammalian evolution [1]. Together, the
embryonic mammary epithelial and mesenchymal tissues
act together as a signalling centre and communicate
back and forth to each other to mediate all stages of
embryonic mammary morphogenesis.
Another key aspect of organogenesis is the formation
of tissue-specific stem cells. To identify at what develop-
mental stage these stem cells first form, mammary pri-
mordia from different embryonic stages have been
implanted into fat pads cleared of mammary epithelium
to evaluate their repopulation capacity, which provides a
measure of stem cell activity within a population. In
these experiments, mammary primordia from E12.5
onwards formed extensive arborised ducts and have
been used to evaluate postnatal mammary phenotypes
in mice with genetic mutations which exhibit embryonic
lethal phenotypes [3]. Moreover, mammary epithelium,
isolated from E13.0 mammary primordia, independent
of mammary mesenchyme, can give rise to all mammary
epithelial cell types in this assay, and can even induce
the formation of milk-secreting mammary alveoli in fat
pads of pregnant females [4]. These observations suggest
that tissue-specific stem cells reside within the primor-
dial mammary epithelium by mid-gestation and that
these cells have the ability to respond to the postnatal
microenvironment in an appropriate fashion. However,
the molecular identity of the epithelial cells in the mam-
mary primordia is still ill defined, and the degree of
similarity to postnatal mammary epithelial cells remains
largely unknown.
To investigate new candidates for inductive tissue
interactions in the mammary primordia, we have now
profiled the gene expression signatures of purified mam-
mary primordia and their epithelial and mesenchymal
tissues in mid-gestation mouse embryos to identify
genes specific for both cellular subpopulations. We have
further compared the embryonic mammary expression
patterns to their postnatal descendants using existing
array data for the basal, luminal estrogen receptor posi-
tive and luminal estrogen receptor negative subpopula-
tions of [5] to identify candidate markers for mammary
progenitor regulators. Comparison of the mammary
mesenchymal and postnatal stromal signatures provides
new insights into likely effectors of mammary cell fate,
lineage promotion and maintenance. Together, our
results provide a global picture of signalling networks
that may regulate key aspects of mammary organogen-
esis, including inductive signalling events, the initial
establishment of the mammary lineage and mammary
progenitor behaviour.
Materials and methods
Sample collection
All animal work was carried out under UK Home Office
project and personal licenses following local ethical
approval and in accordance with local and national
guidelines. Embryonic day 12.5 (E12.5) mammary pri-
mordia number four were manually micro-dissected
from FVB/N embryos in ice-cold D-PBS so that a thick
layer of mesenchyme was left associated with the mam-
mary epithelial bud. Based on histological and confocal
data, the layer of mesenchymal cells consisted of a
depth of approximately 8 to 16 cells and should include
mostly estrogen receptor-alpha (ERa) expressing cells.
Similar micro-dissected samples were digested for two
minutes with pancreatin and trypsin, rinsed extensively
in D-PBS to remove the enzymes. One hour later, pri-
mordia were separated with needles into two cell com-
partments, the mammary bud epithelium and the
mammary bud-associated mesenchyme as described by
[6]. All samples were collected in RLT buffer plus b-
mercaptoethanol and frozen on dry ice. Samples isolated
from pools of 15 to 22 mammary primordia were used
for each biological replicate.
RNA purification
RNA samples were isolated using Qiagen RNeasy Micro
Plus Kit (Qiagen, Hilden, Germany). Quality control,
labelling and microarray hybridisation were performed
at the Paterson Institute for Cancer Research, Molecular
Biology core facility (Manchester, UK).
Target amplification
Three biological replicates for each of the populations
(micro-dissected mammary primordia, purified mam-
mary primordial epithelium, purified mammary primor-
dial mesenchyme) were amplified. Approximately 100 to
150 ng RNA was amplified with NuGEN amplification
(NuGEN Technologies Inc., San Carlos, California,
USA) and hybridised to MOE 430 2.0 Affymetrix arrays
(Affymetrix Ltd, High Wycombe, UK).
Primordial marker expression analyses
Immunohistochemistry (IHC) and whole-mount immu-
nofluorescence (WM-IF) of E12.5 mammary primordia
were performed as previously described [7,8]. Antibodies
used in WM-IF or IHC are listed in Additional file 1.
Whole mount in situ hybridisation of E12.5 mouse
embryos and probes (sense and anti-sense) correspond-
ing to nucleotides of 707-1050 NM_009242 for Sparc,
416-1139 of NM_023655 for Trim29 and 506-1206 of
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described [9].
Quantitative real-time RT-PCR
To compare gene expression between the epithelium
and mesenchyme at E12.5, total RNA was extracted
from the purified mammary primordial compartments
and three replicas were run with Taqman Array Assays-
on-Demand probes on freshly isolated RNA (Applied
Biosystems, Warrington, UK). Results were analysed
with the Δ-ΔCt method normalised to Actb.
Data analysis
Expression data were normalised and summarised by
robust multi-array analysis (RMA) using the affy pack-
age in R. Probe sets were used for a multiclass Signifi-
cance Analysis of Microarray (SAM) to determine if
their mean expression was different across the three pri-
mordial populations. Two-class unpaired SAM was
applied to determine genes enriched in one population
when compared to another using a local false discovery
rate (FDR) of 5%. Probe sets were used for a multiclass
Significance Analysis of Microarray to determine if their
mean expression was different across the three mam-
mary epithelial cell (MEC) subpopulations described in
[5] and the three primordial populations. A total of
4,000 probes identified in the multiclass SAM compar-
ing the embryonic mammary populations with a FDR <
5% were clustered in R. Probes were centred by the
median and clustered on the basis of their correlation
distance using a Ward algorithm. In the embryonic-
postnatal mammary analysis, the top 2,498 probes with
a median absolute deviation (MAD) greater than two
were clustered in R. Probes were centred by the median.
Results were visualised in Java Treeview. Probes were
considered population-enriched when they had a mean
relative abundance of 1.5 or more. The microarray data
have been submitted to the ArrayExpress repository
with accession number [E-TABM-1099].
Network interaction maps were provided by uploading
gene lists into a web-based in-house bioinformatics
package and database, ROCK, developed based on the
pSTIING server [10]. The core interaction maps were
constructed using differentially expressed genes using
only direct interactions characteristic of each population
and produced one large interaction module for each tis-
sue. Genes that did not directly connect are excluded.
Interaction maps are displayed using ROCKscape with
nodes representing proteins and edges representing
interaction or transcriptional regulatory relationships
between components. Sub-modules are identified based
on observation of multiple interconnecting nodes within
node groups that appear on the interaction map as
separable node clusters. The interaction map generated
by connecting the epithelial and mesenchymal popula-
tions was manually curated to ensure that interpolated
connecting genes were appropriate (so that, for instance,
transcription factors did not appear as nodes connecting
genes across the epithelial and mesenchymal popula-
tions). Functional annotation for genes was determined
using the Gene Ontology tool at the Mouse Genome
Informatics website [11] and with the DAVID Bioinfor-
matics Resource [12]. To determine the degree of simi-
larity of gene expression profiles of mammary
primordial cell populations and postnatal mammary and
breast cells, genes considered characteristic of mouse
postnatal mammary cells from [5] or the conserved
mouse-human progenitor cells from [13] were compared
to those of the embryonic mammary cells. The similari-
ties are based on absolute present calls.
Results
Isolation of mammary primordial cell populations
Precise synchronised signals are thought to mediate the
initial stages of mammary primordial development, since
early stages of mammary morphogenesis progress in a
highly stereotypical manner [14]. A limited amount of
cell proliferation is observed within the mammary pri-
mordial epithelium during the early stages (E11.0 to
E13.5) of mammary organogenesis. Localised cell move-
ments are, therefore, thought to increase epithelial cell
number during these stages of mammary development.
To identify candidate signalling pathways and networks
that are active during mammary organogenesis at a
stage in which mammary inductive signalling and stem
cell delimitation are occurring, we have generated data
to define the mammary primordial transcriptome from
stage E12.5 mouse embryos. This entailed micro-dissec-
tion of the fourth pair of mammary primordia from two
or three litters of FVB/N embryos for each replicate
(Figure 1A-C). In a second set of experiments, we sepa-
rated the micro-dissected mammary primordia into
their epithelial and mesenchymal cell populations (Fig-
ure 1D, E). In all experiments, the dissected mammary
primordia included several layers of surrounding cells to
gather the ERa-positive mesenchymal cells, which are
arranged in layers of concentric circles around the
mammary bud epithelium (Figure 1A, B).
Gene expression profiling of mammary primordia and
their epithelial and mammary mesenchymal cell
populations
RNA was isolated from micro-dissected mammary pri-
mordia, and mammary primordial epithelium and
mesenchyme from matched tissue pools. RNA was
labelled by Nugen amplification and hybridised to MOE
430 2.0 Affymetrix arrays. Significance Analysis of
Microarray (SAM) was applied to identify genes showing
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cell populations at an FDR < 0.05. Using these para-
meters, 4,000 probes were found to be differentially
expressed among the enzymatically separated tissues
and the micro-dissected primordia which were included
to assess whether probes expressed by the separated tis-
sues were present in the intact primordial samples (Fig-
ure 1F and Additional file 2). A total of 749 probe genes
were upregulated 1.5-fold or greater at an FDR < 0.05 in
the primordial epithelium compared to its associated
mesenchyme when the mean relative abundance was 1.5
or greater (Additional file 2). Known key regulators of
normal mammary primordial development, including
Edar, Fgfr2, Gata3, Msx1, Msx2, Nrg3, Pthlh, and multi-
ple Wnt signalling components were expressed specifi-
cally within the embryonic mammary epithelium when
compared to the mesenchyme (Additional file 2)
[15-23]. Amongst these, 25 genes were already known
to be expressed in mid-gestation mammary primordia
(Additional file 2). The technique used to separate the
two tissues had relatively little effect on gene expression
(Additional file 2). Using quantitative qRT-PCR, whole
mount in situ hybridisation (WM-ISH), whole mount
immunofluorescence (WM-IF), immunofluorescence (IF)
and immunohistochemistry (IHC) we confirmed epithe-
lial-enriched expression for 18 genes (Figure 2A, B). In
Figure 1 Cell populations profiled to define the mammary primordial transcriptome. (A) E12.5 mammary primordium stained with DAPI;
the amount of mammary mesenchyme (MM) and dermal mesenchyme (DM) left associated with the mammary bud epithelium (MBE) upon
microdissection are indicated. (B) Immunofluorescence with ERa shows stains throughout the mesenchymal tissue that was isolated. Scale bar is
50 μm. (C) Microdissected mammary primordium (MP). (D) Mammary bud epithelium after tissue separation. (E) Mammary primordial
mesenchyme after tissue separation. (F) Heatmap and supervised clustering of differential gene expression across mammary primordial tissues
with probe sets with the most tissue-specific expression. Each horizontal line represents a probe set with red indicating high and green
indicating low expression.
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Epcam are expressed by many mammary primordial epithelial cells at high levels while some cells do not stain or express lower levels of these
markers. All mammary primordial epithelial cells express p63. Laminin stains along the epidermal-mesenchymal boundary. Ctnnb1/b-catenin and
Itgb4 are expressed at varying levels by cells within the primordia. Trim29 is expressed predominantly by basal cells. Scale bar is 50 μm. (B) qRT-
PCR analysis of RNA from enzymatically separated E12.5 mammary bud epithelium (MBE) and mammary mesenchyme (MM). Gene RNA levels are
expressed relative to Actb levels. Error bars ± s.e.m. Validation of eight mammary bud epithelium (MBE) specific genes showing enriched
expression when compared to the mammary mesenchyme (MM). (C) A kinase-activin receptor sub-module is detected by network analysis. This
sub-module forms part of the core network module generated using human orthologues of physically interacting genes characteristic of E12.5
mammary primordial epithelium. Black lines represent protein-protein interactions.
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factors, receptors, and transcription factors not pre-
viously ascribed to the embryonic mammary epithelium
(Additional file 3). RNA and protein expression studies
have validated several population-enriched gene expres-
sion profiles detected by the array analysis and indicate
the dataset represents a reliable global genetic profile of
the primordial cell populations.
Transcriptional network of mammary primordial
development
A core network module (Additional files 3 and 4) was
generated using ROCKscape, a modification of Cytos-
cape [24,25] by using the human orthologues of genes
expressed by the E12.5 mammary primordial epithelium,
as described in Additional file 2; only genes encoding
proteins that have previously been shown to directly
interact with each other were used to make this net-
work. HEAT SHOCK PROTEIN 1 (HSPB1)i st h e
mostly highly connected node and links to a keratin
sub-module that is poised to maintain the structural
integrity of the primordial epithelium. Other highly con-
nected nodes include b-CATENIN (CTNNB1), an
adherents junctions component and major effectors of
Wnt signalling, PLAKOGLOBIN (JUP), PI3-KINASE
(PIK3R1) and the actin-binding mediators, DUCHENNE
MUSCULAR DYSTROPHY (DMD)a n dA C T I N - B I N D -
ING LIM PROTEIN 1 (ABLIM1). Less connected nodes
include a kinase activin receptor sub-module (Figure
2C), a collagen-PDGF sub-module, an integrin/cell
adhesion sub-module and a receptor-signalling sub-
module. These sub-modules consist of genetic elements,
many with established roles in the regulation of epithe-
lial signalling and morphogenesis, including genes
involved in focal adhesion, cell contractility, cell-matrix
adhesion, and extracellular matrix (ECM)-receptor inter-
actions. The sub-module in Figure 2C contains one
node, DISCOIDIN RECEPTOR 1 (DDR1)w h i c hi s
known to regulate both branching morphogenesis and
terminal differentiation in the postnatal mammary gland
a n di sp o i s e dt oi n t e r a c tw i t ht w oa c t i v i nr e c e p t o r s ,
represented by nodes ACVR1B and ACVR2B [26]. Inhib-
bin-B, a ligand for both activin receptors, is required
during puberty and pregnancy for normal mammary
ductal elongation and alveolar development [27]. This
sub-module is, therefore, likely to represent biologically
relevant interactions, since branching morphogenesis is
a modified version of budding morphogenesis (that is,
when a cluster of progenitor cells located within distinct
boundaries moves, rearranges and proliferates to form
an organ) and also identifies other kinases as novel
potential bud morphogenetic regulators. Some signals
within the epithelial cells should represent responses
that have been induced by the mesenchyme (that is,
activated receptors and their downstream effectors) as
well as signals that will be sent to the mesenchyme
(secreted factors).
A limitation of networks based on transcriptomic stu-
dies is that mRNA and protein levels do not always cor-
relate. To address this to a small extent and further
refine our understanding of the signalling characteristics
of the primordial cells, we focused on validating expres-
sion patterns of markers within our network interaction
maps using immunohistochemistry or immunofluores-
cence, rather than only qRT-PCR and ISH. Immunohis-
tochemical analysis can be used to determine whether
key nodes (based on number of interactions with other
nodes and/or previous association with lineage) are pre-
sent at the protein level and, therefore, are potentially
signalling. This approach also permits detection of the
precise location and fraction of cells within the mam-
mary primordium that express putative effectors. One
notable epithelial core network member, Trim29,
appears to be restricted to the basal epithelial layer of
the mammary epithelium at stages prior to the polarised
postnatal localisation of the classic basal Keratins, Krt5
and Krt14, which are expressed by many basal and
suprabasal mammary epithelial cells at E12.5. Trim29,
therefore, represents one of the first mammary primor-
dial markers expressed in a basally-enriched pattern,
aside from the basal lamina components (Figure 2A).
Trim29 can interact with Krt17, a keratin associated
with stratification of epithelial appendages [28], which is
expressed by basal cells of the postnatal mammary
epithelia [5]. The location of Trim29 within the sub-
module highlights a likely role in regulating processes
related to both cell structure and lineage. In the postna-
tal mammary epithelium, keratins become predomi-
nantly segregated by expression within MECs of either
the myoepithelial (Krt5, Krt14, Krt17) or luminal
lineages (Krt8, Krt18).
Population-enriched expression was observed for 642
probes at FDR < 0.05 in the mammary mesenchyme
associated with the mammary primordium when com-
pared to the epithelium when the mean relative abun-
dance was 1.5 or greater (Additional file 2). We detected
the previously reported mesenchymal-enriched expres-
sion of Fgf7, Tbx15,a n dTnc [17,29-31]. We confirmed
mesenchymal-enriched expression for 13 genes using
q R T - P C R ,W M I S H ,a n dW M - I F( F i g u r e3 A ,B ) .M a j o r
transcriptomic pathway components expressed specifi-
cally within the mammary mesenchyme are summarised
in Additional file 5, including many growth factors,
receptors, and transcription factors. A core network
module (Additional file 5 and 6) was generated using
ROCKscape based on the human orthologues of directly
interacting genes characteristic of the mesenchyme asso-
ciated with the E12.5 mammary primordial epithelium
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module comprised of G protein coupled receptor signal-
ling and cytokine signalling is evident and contains key
mediators of metastasis and invasive growth, such as
CXCR4 and its ligand CXCL12/SDF [32] (Figure 3C).
This sub-module connects to another highly
interconnected sub-module comprised of cytoskeleton
and cell movement components via the node, GELSO-
LIN, (GSN). The actins binding protein, (Gsn), is
required in postnatal stroma for proper mammary duc-
tal elongation into the fat pad during puberty and this
phase of invasive growth is very delayed in its absence
Figure 3 Validation and network analysis of mammary mesenchyme microarray data. (A) ERa and TnC stain the mammary mesenchyme.
Most mammary mesenchymal cells express Sparc, except for those directly adjacent to the bud epithelium. Dlk1 and CD248/Endosialin stain all
mesenchymal cells. Cav1 and Tmeff2 are expressed at higher levels by distinct cells. Nrp2 appears to be expressed by neural cells. Scale bar is 50
μm. (B) qRT-PCR analysis of RNA from enzymatically separated mammary bud epithelium (MBE) and mammary mesenchyme (MM). Gene RNA
levels are expressed relative to Actb levels. Error bars ± s.e.m. Validation of nine MM specific genes enriched expression when compared to the
MBE. Tcf4 did not show population specific expression by this analysis. (C) A sub-module comprised of several highly interconnected nodes
representing G protein coupled receptor signalling and cytokines forms part of the core network module of mammary primordial mesenchyme.
This core network was generated using human orthologs of directly interacting genes characteristic of the mammary mesenchyme. Black lines
represent protein-protein interactions. Nodes that have been shown to interact in complexes are connected together by yellow-green lines.
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the regulation of embryonic mammary epithelial mor-
phogenesis, the network analysis identifies connections
to plausible interaction partners since both CXCR4 and
CXCL12/SDF have well-established roles in invasive cell
behaviour. Many mesenchymal nodes represent genes
involved in angiogenesis, chemotaxis, and neural path-
finding (Additional file 6). One node, NEUROPILIN2
(NRP2), is highly expressed in the mammary mesench-
yme array data and was validated by qRT-PCR (Figure
3B); Nrp2 appears to stain nerves (Figure 3A) whilst
other markers appear to stain forming blood vessels in
the mammary mesenchymal region that was dissected
out and profiled (Figure 1A). This indicates that despite
its indistinct and homogenous cellular appearance,
mammary mesenchymal components (neural, vascula-
ture, fat cells) indicated by signature, pathway, and net-
work analyses are likely to reflect ongoing
developmental processes associated with specific cell
types. Some mesenchymal markers are expressed in sub-
domains that could represent or promote the formation
of distinct sub-compartments within the mammary
mesenchyme.
Potential mammary-inducing factors, lineage promoters
and key signalling processes identified
By E13.0, embryonic mammary mesenchyme from mice
can induce surface epithelium to adopt a mammary cell
fate [34], so E12.5 mammary mesenchyme should be
enriched for mammary inducing factors. Postnatal stro-
mal cells are not thought to harbour mammary induc-
tive potential. Factors with the potential to transmit
mammary-inductive signals were identified by analysing
gene expression profiles enriched within the mammary
mesenchyme compared to stromal signatures described
in [13]. Several secreted factors including Dlk1 and
Gas1, fulfil this criterion and as such are potential mam-
mary-inducing factors (Additional file 7).
To identify potential promoters of mammary differen-
tiation from the inception of the mammary lineage
onwards, we compared genes expressed by the mam-
mary mesenchyme with genes expressed by the mam-
mary stroma profiled by [13] (Additional file 8). Genes
expressed by both tissues could promote mammary dif-
ferentiation throughout mammary development and act
as lineage reinforcers to maintain mammary cell iden-
tity. Several secreted factors are classified as potential
mammary lineage reinforces including, Ccl11, Dab2,
Dcn, Igf1, Fgf7, Figf, Gpc3, Sparcl1, Slit2, Thbs2, Tmeff2,
and Wisp1 (Additional file 8). These molecules could
signal directly to the primitive and mature MECs to
promote mammary cell fate. In addition, several tran-
scription factors also fall into this category, including
Ebf1, Ebf3, Gata6, Klf4, Maf, Nr2f1, Osr2, Prrx1, Prrx2,
Tcf4, Tbx15,a n dTbx18, which may contribute to pro-
motion of the mammary cell fate via transcriptional reg-
ulation of other particular key factors that can transmit
signals to the adjacent MECs. Comparison of genes
expressed by the mammary mesenchymal cells with
genes expressed by human breast stromal cells identifies
some common genes (Additional file 8). This may indi-
cate a conserved function of some stromal signals across
species with respect to mammary lineage promotion and
maintenance.
The mammary primordial epithelial and mesenchymal
core network modules were interconnected to identify
prospective mediators of mesenchymal-epithelial inter-
actions (Additional file 9). Some of the putative mam-
mary inductive signals expressed by cells in the
mammary mesenchyme are found in the core intercon-
nected network module and plausible signalling partners
or signalling components have been identified in the
mammary bud epithelium (Figure 4A, B). For example,
Decorin (Dcn) is expressed by mesenchymal cells imme-
diately adjacent to the mammary bud epithelium (Figure
4C). Decorin, a proteoglycan, is secreted and thus poised
to interact with epithelial cells expressing Col4a5 and
Col4a6 (CollagenIV) at the epidermal-mesenchymal
boundary (Figure 4D). Studies of Dcn-null mice have
i d e n t i f i e dar o l ef o rDcn in the regulation of collagen
fibril assembly which is thought to lead to the formation
of a barrier to cell penetration and macromolecule infil-
tration [35]. Decorin has also been implicated in the
modulation of both postnatal mammary stromal cell
phenotypes and MEC behaviour in tumours [36], sug-
gesting that Decorin may play a regulatory role in med-
iating mammary tissue interactions from early
developmental stages onward. Established regulators of
mesenchymal to epithelial signalling such as Inhbb (acti-
vin/inhibin beta b) are represented in this network
(Additional files 9 and 10). Several secreted factors are
found that could interconnect nodes to mediate signal
transduction across the two tissue compartments via
paracrine signalling (Figure 4A). Many interactions that
are poised to connect the epithelial and mesenchymal
cells (by virtue of their compartment-enriched expres-
sion and known ability to interact) could modulate
extracellular matrix organisation and cell adhesion and
would, therefore, profoundly alter the microenvironment
of progenitor cells in the basal layer of the epithelium.
Comparison of gene expression profiles of mammary
primordial cell populations reveals similarities and
differences with their direct descendants
The mammary primordial populations profiled were iso-
lated from the fourth primordial (of the five pairs) from
the FVB strain so a direct comparison to the postnatal
mammary epithelial cell sub-populations (basal, luminal
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from the FVB strain and the fourth (inguinal) mammary
gland (Figure 5A and Additional file 11) [5]. As such,
the postnatal cells should represent the descendants of
the primordial cells. Three major classes of genes can be
identified: those expressed within the postnatal cell
populations and not expressed by the primordial cells
(postnatal mammary), those expressed within the pri-
mordial cells and not expressed by the postnatal cells
(embryonic mammary), and those that are expressed by
Figure 4 Prospective mediators of epithelial-mesenchymal interactions identified by network analysis. (A) List of likely effectors of
inductive signalling across the mesenchymal-epithelial boundary. In addition to ligand-receptor pairs, inter-connections between known
signalling cascade components that could transmit signals across the mammary mesenchyme (MM) and the mammary bud epithelium (MBE)
and vice versa are shown. (B) Mesenchymal Decorin (Dcn) is poised to interact with both epithelial CollagenIVa5 and CollagenIVa6 (Col4a5 and
Col4a6). Red represents mesenchymal nodes. Green represents epithelial nodes. (C, D) Decorin and CollagenIV expression patterns suggest that
these interconnected nodes represent feasible biological interactions that could modulate signals both within the extracellular matrix and
basement membrane and across the mesenchymal-epithelial boundary. Scale bar is 50 μm.
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tions (shared embryonic/postnatal mammary) (Figure
5A). Gene expression patterns shared between primor-
dial and postnatal mammary sub-populations may
represent effectors capable of impacting mammary cell
behaviour regardless of their level of differentiation (Fig-
ure 5B and Additional file 12). The mammary primor-
dial epithelial cells are an immature mammary epithelial
Figure 5 Transcriptome analysis reveals similarities and differences between embryonic and postnatal mammary cell populations. (A)
Heatmap and unsupervised cluster analysis of differential gene expression across postnatal mammary epithelial cells (MECs) and mammary
primordial populations. Each horizontal line represents a probe set with red indicating high expression and green indicating low expression in
the various tissue compartments. (B) Venn diagrams showing the number of shared and unique genes expressed within mammary primordial
compartments compared to the three postnatal mouse MEC subpopulations. (C) Arrows indicate cells expressing nuclear Sox9 within the surface
and primordial epithelium. Control tissue shows strong nuclear staining in the developing ribs (arrows) and spinal cord (arrowheads). Strong
Vimentin expression is observed in the periderm, surface epithelium and mammary mesenchymal cells. Arrow indicates a mammary primordial
epithelial cell expressing Vimentin. Most suprabasal cells of the mammary primordial epithelium express E-cadherin; less intense expression is
observed in the periderm and surface epithelium above the mammary bud and some suprabasal cells (arrows). Trps1 stain is non-nuclear within
the mammary bud epithelium. Vibrissae mesenchyme shows nuclear stain while some non-nuclear staining is observed in the epithelium at
E12.5 (Control). Diffuse CD24 is observed in E12.5 mammary mesenchyme. At E16.5, the mammary bud epithelium and some cells within the
mammary mesenchyme express CD24 (Control). A few Nestin-expressing cells are observed within both mammary epithelial and mesenchymal
primordial cells. Strong Nestin staining is observed in embryonic nerves at E12.5. Some c-Kit positive cells are observed within the mammary bud
epithelium and mesenchyme. Positive control is roof of brain ventricle at E12.5. Erbb2 expression is observed in mammary bud epithelial and
some mesenchymal cells at E12.5. SMA is observed in a blood vessel (arrow) adjacent to the mammary bud epithelium, which does not express
SMA. Both the mammary bud epithelial and mammary mesenchymal cells express Lef1 and CD29. Scale bar is 50 μm. MBE denotes mammary
bud epithelium. MM denotes mammary mesenchyme. MP denotes mammary primordium. LumER- denotes luminal estrogen receptor negative.
LumER+ denotes luminal estrogen receptor positive.
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types, such as ERa, which is expressed by cells in the
luminal ER+ population or SMA which is expressed by
myoepithelial cells which comprise the bulk of the basal
population (Figures 1B and 5C) [37].
We also compared our embryonic mammary gene sig-
natures to the terminal end bud (TEB) and mature duc-
tal signatures derived from the dataset described by
Kouros-Mehr and Werb [38]. This dataset represents
profiles of micro-dissected tissues containing both
epithelial cells and immediately adjacent stroma at pub-
erty, a key developmental stage during which the TEB
exhibits invasive directional growth through the fat pad,
resulting in ductal elongation and branching. We found
a small number of genes expressed by embryonic mam-
mary cells and ductal or TEB cells, including Anxa8,
Dlx3, Kitl, Klf4, Pthlh, Sema3c. Sox11, Sox18, Thbs1,
Trps1, Wnt6,a n dWnt7b. Genes expressed at both of
these critical developmental stages may represent master
mammary morphogenetic or lineage regulators (Addi-
tional files 12 and 13). Of these, some are also expressed
by human stromal cells including Col3a1, Fbn1, Igf1,
Kera, On, Ptgis, Thbs2, Timp3, Tmeff2, and Vcam1.
By E13.0, the mammary primordial epithelium is
determined to mammary cell fate, so at this slightly ear-
lier developmental stage, E12.5, profiled here, the primi-
tive mammary epithelium is either stably or nearly
determined to the mammary lineage and, therefore,
genes regulating mammary progenitor cell function
should be expressed. Since other organs express the
same transcription factors in stem/progenitor cells at
both embryonic and postnatal stages, we looked for
shared transcriptional programs across the embryonic
and postnatal mammary cells to ascertain potential tis-
sue-specific transcription factors and other signalling
regulators, which we predict should be involved in
mammary cell fate and progenitor function (Additional
file 13). Examples of transcription factors that are
expressed in both primordial and postnatal MEC sub-
populations and have critical roles in regulating progeni-
tor biology include Elf5 and Sox6 [5,39]. Several mam-
mary stem cell-enriched and progenitor-enriched
markers are expressed by the mammary primordial cells
(Figures 2A, 5C and Additional file 13).
Comparison of the primordial populations to the post-
natal mammary cell populations reveals subsets of genes
that are expressed within both the mammary primordial
epithelium and associated mesenchyme (Figure 5A and
Additional file 13). Some of these include classic EMT
genes, including Twist1 and Twist2, which are associated
with loss of epithelial characteristics when expressed by
adherent epithelial cells and acquisition of mesenchymal
features (Additional file 13). Confocal analysis of the
mammary primordium shows a very heterogeneous
population of cell types, some with a nucleus and shape
resembling fibroblasts (Figu r e1 A ) .W eh a v ef o u n dt h a t
a small population of the primitive mammary epithelial
cells express an epithelial-mesenchymal transition
(EMT)-associated marker Sox9 and Vimentin, a
mesenchymal marker expressed by some bona fide
epithelial cells, as well as those undergoing EMT (Figure
5C). Myoepithelial cells also express EMT-associated
genes so their expression by the various mammary cell
populations is likely to reflect their shared developmen-
tal origin from the basal epithelium, including an under-
lying transcriptional program that acts to repress
epithelial differentiation and promote cell motility. Pri-
mordial epithelial cells with EMT features may have
great pertinence to the initial generation of mammary
stem cells since recent data suggest that induction of
EMT stimulates cultured breast cells to adopt character-
istics of stem cells [40].
Comparison of gene expression profiles of mammary
primordial cell populations reveals transcriptomic
similarities to human breast progenitor profiles
We also compared genes expressed in both the mam-
mary primordium and the subpopulations of MECs that
are conserved across mouse and human, which have
recently been described [13]. We observed some over-
lapping gene expression with the primordial cell popula-
tions and the “mammary stem cell (MaSC)” populations,
luminal progenitor and mature luminal populations
(Additional file 13). Genes with established or antici-
pated roles in mammary progenitor biology, including
Itga6 and Msx1, are expressed by the mammary primor-
dial cells, and by the conserved mouse-human mam-
mary progenitor populations (Additional file 14). Many
genes expressed by both the primordial and conserved
mouse/human mammary stem cell-enriched populations
are also found within the core network modules which
suggests that the primordial core networks reflect ele-
ments regulating fundamental biological processes, with
many poised to impact progenitor cell behaviour.
GSEA detects similarities to other progenitor populations
Gene expression profiles of the embryonic and mam-
mary postnatal cells are largely unique with a limited
amount of overlap (Figure 5A, B). Primordial population
signatures were used in gene set enrichment analysis
[41]. When compared to the luminal postnatal MEC
subpopulations, the mammary primordial epithelium
displays enrichment for Wnts, Hox genes, phosphatidyli-
nositol, insulin signals, and gene signatures found up-
regulated in many hematopoietic progenitor classes.
When compared to the basal MECs, the mammary pri-
mordial epithelium is enriched for Hox genes, phospha-
tidylinositol, and insulin signals, but is not enriched for
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15). This indicates that the embryonic mammary cells
share some genetic features wit ho t h e rp r o g e n i t o rc e l l s ,
particularly hematopoietic types.
Discussion
The results presented here give a global picture of the
signalling events that may occur as the mammary line-
age is first established during mammary primordial
organogenesis. Mammary primordial epithelial cells
express a distinct entity of genes when compared to
those present within the adjacent mammary mesenchy-
mal cells (and vice versa). We have used these gene sig-
natures to define the transcriptomic specificity and
signalling cascades that are likely to be mediating reci-
procal epithelial-mesenchymal interactions that regulate
early mammary tissue organisation, architecture, differ-
entiation and cell fate decisions. Inducing factors such
a sN r g 3 ,E d a ,F g f ,a n dW n ts i g n a l sh a v eb e e ns h o w nt o
promote either mammary cell fate and/or epidermal
appendage development and key components of these
pathways are detected in our analysis [17,19,20,42]. The
network maps show how many of the genes expressed
by the mammary primordium might converge to elicit
complex processes required for morphogenesis such as
changing cell adhesion to allow local cell movements
required during budding morphogenesis.
Since mammary mesenchyme is an instructive tissue, a
strong component of its cell function should be to pro-
mote mammary lineage establishment. The mammary
primordial epithelial cells profiled here should be receiv-
ing signals from the mesenchyme representing key
aspects of mammary cell fate acquisition. Comparing
gene expression enriched within mammary mesenchyme
to that enriched within postnatal mammary stoma iden-
tified factors with potential to transmit mammary-indu-
cing signals. Notable candidates with potential
mammary-inductive signalling roles include Gas1, which
regulates the range and the level of Hedgehog signalling,
since down-regulation of Hh signalling is absolutely
required for mammary development to proceed [43-45].
Dlk1, an endogenous inhibitor of Notch, could act to
repress Notch signals in the mammary primordial
epithelium; Notch controls cell fate and tissue homeos-
tasis in postnatal mammary epithelium and could be
regulating stem cell function from the time that they
arise [46]. Other genes of interest include Arhgap28 and
Centd3 since another Rho-GTPase activating protein-
encoding gene, Arhgap5, has been shown to regulate
epithelial-mesenchymal interactions necessary to sustain
mammary bud morphogenesis [47].
This approach to classifying molecules may be useful
for identifying likely mediators of mammary inductive
signalling for further study but all diffusible factors
expressed by the mammary mesenchyme are potential
mammary inducing factors. Signals from purified mam-
mary mesenchyme (isolated using similar methods used
in this study) can induce mammary glandular tissue
when recombined with simple epithelium across species
(mouse to rat) and (rabbit to chicken and duck) so the
putative paracrine interactions identified here are likely
to occur in other species, including human [34,48]. A
recent study showed that embryonic prostate mesench-
yme acts to induce prostate lineage markers in tissue
recombinants using several types of non-prostate post-
natal epithelium [49]. This notable study supports the
contention that mesenchymal and stromal tissues act as
lineage enforcers which send signals to epithelial cells to
promote and maintain differentiation along a specific
lineage. The interconnected epithelial-mesenchymal
nodes in our network map predominantly involve sig-
nals that involve basal lamina and ECM components
and many, such as the integrins, have established roles
as cell differentiation and cell adhesion regulators which
impact cell shape, changes in cell contact, and cell
movements, consistent with the morphogenetic pro-
cesses that these tissue interactions invoke.
Epithelial Pthlh to mesenchymal Pthr signalling is
required for the formation of the mammary mesench-
yme and the induction of Tnc expression [29]; Pthlh
represents the most abundant gene expressed by the
embryonic mammary epithelium in our dataset. A
recent study profiling genes expressed by micro-dis-
sected E15.5 stage Pthlh-/- and wild-type mammary pri-
mordia, to study ductal morphogenesis, detected many
changes in genes expression by the Pthlh mutant pri-
mordia, consistent with Pthlh signalling being a key
component of mammary primordial development [50].
However, this analysis did not permit the identification
of which of the two tissues the candidates genes were
expressed within since the primordia were not separated
into their two tissue components. We detected expres-
sion of several of the candidate genes that appear to be
regulated by Pthlh/Pthr signalling in our core intercon-
nected mammary primordial network module (including
INHBB, KRT8, KRT18, KRT19, MATN2, SOSTDC1,
TGFBI, THBS1, NRP1, WISP1 and TNC) giving a more
precise indication of how this signalling cascade could
proceed and connect diverse pathways across the tissues
to control reciprocal mesenchymal-epithelial Pthr/Pthlh
signals. Our core network reflects signals from an earlier
developmental stage (E12.5) at which it is conceivable
that Pthlh and Pthr signals are already actively inducing
formation of the mammary mesenchyme. The Pthlh/
Pthr regulated genes identified by [50] found in our
E12.5 networks are, therefore, likely to reflect some key
elements that confer or maintain instructive properties
to the mammary mesenchyme. This indicates our
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inductive events and should be useful for identification
of novel putative inductive signalling effectors, which
can be tested for roles as embryonic mammary develop-
ment regulators using either transgenic or knockout
mouse models, which should soon be available for most
genes via ongoing large-scale mouse genome initiatives.
As more genes and pathways are determined to regulate
embryonic mammary primordial development, these
networks can be extended and expanded which will per-
mit assessment of potential genetic hierarchy and path-
way convergence and aid experimental design to clarify
these issues.
Although the mammary primordium should in theory
be predicted to be enriched for stem cells, previous
functional analysis suggests that only a very small frac-
tion of the primordial epithelial cells can fulfil the stan-
dard definition currently used to assay for mammary
stem cell function, that is, the repopulating capacity in
the cleared postnatal fat pad [4]. It is possible that this
assay is not particularly appropriate for establishing
stem cell activity of primordial cells since it selects for
more mature stem cells and may exclude less-mature
embryonic progenitor cells that are incapable of inter-
acting with the postnatal microenvironment yet fulfil
stem cell criterion within their native microenvironment
in vivo (that is, they undergo self-renewal and are cap-
able of giving rise to other cells types). Results from
gene set enrichment analysis indicate that the primordial
cell populations share some transcriptomic features with
other progenitor populations from both embryonic and
postnatal tissues, particularly hematopoietic progenitors.
Recently, s-SHIP promoter expression has been shown
to mark activated stem cells in postnatal mammary tis-
sue [51]. It is, therefore, notable that mammary primor-
dial epithelial cells express GFP driven by the s-SHIP
promoter [52], which indicates that the mammary pri-
mordial epithelial cells may represent a population of
activated primitive mammary progenitor cells. Although
by E13.0, the mammary epithelium is determined as
mammary, it is highly likely that a large degree of plasti-
city exists with respect to how committed, (if at all) any
of the individual primordial cells are to any particular
progenitor type (stem, bipotent, myoepithelial precursor,
luminal precursor) within the mammary hierarchy at
this stage of development and remains to be explored.
Our results show that substantial transcriptomic dif-
ferences exist between embryonic mammary cells and
postnatal mammary cells, which are most likely due to a
unique microenvironment and their immature state.
Despite this, the primitive embryonic epithelial and
mesenchymal cell populations express a number of
genes that have been shown or suggested to regulate
postnatal progenitor mammary cell functions. The
conserved expression patterns observed across the pri-
mordial and postnatal MEC sub-populations suggest
that some molecular mechanisms that govern mammary
stem cell homeostasis are active as the lineage is first
established and continue to regulate this function
throughout postnatal development. The early embryonic
expression of several known mammary lineage regula-
tors within the primitive mammary epithelium lends
support to this idea. In particular, lack of Gata3,o n eo f
the most highly expressed genes expressed by the
embryonic mammary epithelium in our analysis, leads
to defective mammary primordial development at stages
prior to E12.5 [21].
Conclusions
The pathways implicated in cell fate decisions are clearly
relevant to transformation as most forms of breast can-
cer involve deregulation of signalling pathways (Egg, Fgf,
Notch, Wnt) that also determine cell identity when cells
are initially specified from undifferentiated precursor
cells [53]. Embryonic mammary developmental studies
will be key to determining how the mammary primor-
dial cells may differentiate and perpetuate amidst a vari-
ety of other cell types and signals to first establish an
environment or niche for the penultimate mammary
progenitor cells. Functional studies of the mammary
mesenchyme have demonstrated its profound role in
directing and maintaining normal mammary tissue dif-
ferentiation and architecture; mammary mesenchyme
can restore some features of differentiated tissue to
mouse mammary tumours when grown together in cul-
ture [54]. The identification of molecular effectors that
may contribute to the creation of the primitive mam-
mary epithelial and stromal populations provides a basis
for selection of novel candidate regulators of mammary
lineage establishment, maintenance, and differentiation
for further study in both mouse models and cell-based
systems. The dataset and analysis presented here repre-
sent a framework for studying how cells communicate
and act together to produce the organ that defines and
sustains all mammals.
Additional material
Additional file 1: Antibodies used in expression analysis
experiments. Table gives details of antibodies used in this study.
Additional file 2: The mammary primordial transcriptome. Table A
displays relative expression levels of 4,000 Affymetrix probes across three
embryonic mouse mammary primordial populations. The spreadsheet
gives the relative expression levels for all differentially expressed probes
across all three populations. Expression levels are indicated by a relative
abundance score for each population. A high positive value indicates
expression at a high level, a low negative score indicates very low
expression levels. The Affymetrix probe ID, Gene Symbol and q-value
(indicating the % false discovery rate) are also indicated. Table B contains
genes characteristic of mammary primordial epithelial cells. The table
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Page 13 of 16shows all 749 probes in the mammary primordial epithelial population
with an abundance score of 1.5 or more when the differentially
expressed gene set was sorted by descending abundance scores in the
epithelial population. Such genes were considered population-enriched.
The number of probes is indicated. Table C contains probes with known
expression patterns that were detected as epithelial-specific or epithelial-
enriched expression in the arrays. Table D contains probes induced or
repressed by tissue separation. Table E contains genes characteristic of
mammary primordial mesenchymal cells. The table shows all 642 probes
in the mammary primordial mesenchymal population with an
abundance score of 1.5 or more when the differentially expressed probe
set was sorted by descending abundance scores in the primordial
epithelial population. Such genes were considered population-enriched.
Additional file 3: Transcriptomic characteristics of the mammary
primordial epithelium. (A) A figure summarising select genetic
components of the mammary primordial epithelium detected by array
analysis. (B) A figure depicting network analysis of the mammary
primordial epithelium.
Additional file 4: Mammary epithelial primordial core network
members. Table contains mammary epithelial core network members.
Additional file 5: Transcriptomic characteristics of the mammary
mesenchyme. (A) A figure summarising select genetic components of
the mammary mesenchyme detected by array analysis. (B) A figure
depicting network analysis of the mammary mesenchyme.
Additional file 6: Mammary mesenchymal primordial core network
members. Table contains mammary mesenchymal core network
members.
Additional file 7: List of candidate mammary inducing factors with
Gene Ontology. This table contains expression patterns of genes
enriched in primordial-associated mesenchyme when compared to
postnatal mammary stroma in a previously published dataset [13]. Gene
expression patterns were overlaid in order to discern enriched secreted
factors present only in the mammary mesenchyme that could confer
mammary cell phenotype to uninduced surface epithelium.
Additional file 8: Lists of candidate mammary lineage promoting/
enforcing factors. Table A contains genes expressed by both the
mammary mesenchyme and the mature mammary stroma in a
previously published dataset [13]. These genes are candidates for
promoting mammary differentiation or enforcing mammary lineage
commitment. Table B contains genes expressed by human mammary
stromal cells in a previously published dataset [55] which were also
found expressed by the mammary mesenchymal cell populations in the
current study.
Additional file 9: Prospective mediators of epithelial-mesenchymal
interactions identified by network analysis. (A) A figure depicting the
core interconnected network module. (B) A figure depicting how
mesenchymal INHBB is poised to bind to epithelial ACVR1B and ACVR2B.
Additional file 10: Core interconnected network members with
Gene Ontology. Table contains core interconnected network members
with Gene Ontology.
Additional file 11: Multiclass SAM analysis of embryonic and
postnatal mammary populations. This table displays relative expression
levels of 16,382 Affymetrix probes across three embryonic mouse
mammary primordial populations and three postnatal mammary
epithelial populations. The spreadsheet gives the relative expression
levels for all differentially expressed probes across all six populations.
Expression levels are indicated by a relative abundance score for each
population. A high positive value indicates expression at a high level, a
low negative score indicates very low expression levels. The Affymetrix
probe ID, Gene Symbol and q-value (indicating the % false discovery
rate) are also indicated.
Additional file 12: Genes expressed by embryonic mammary cells
and postnatal mammary cells. This table contains genes common to
primordial cells and basal cell dataset and luminal cell datasets from [5].
The table lists those basal genes, LumER- genes, and LumER+ genes
found in a previously published dataset [5] which were also found in the
primordial epithelial or mesenchymal populations in the current study. A
mouse stromal signature from [13] was used to determine which genes
were also found in the primordial epithelial or mesenchymal populations.
Genes expressed by embryonic mammary primordial cells and the cells
contained within the terminal end bud and ductal microenvironments
from [38] are also listed.
Additional file 13: Comparison of gene expression profiles of
embryonic mammary cells with postnatal mammary cells. (A) Venn
diagrams showing comparison of genes expressed by embryonic
mammary primordial cells to those expressed by the cells contained
within the terminal end bud and ductal microenvironments from [38].
(B) A heatmap showing the expression of a variety of key
developmental, lineage, and progenitor markers in embryonic and
postnatal mammary cell populations. (C) Venn diagram showing
comparison of genes expressed by embryonic mammary primordial cells
to those expressed by the conserved mouse/human MEC subpopulations
and human fibroblasts from [13,55].
Additional file 14: Genes expressed by embryonic mammary cells
and human breast cells. This table contains genes common to
primordial cells and conserved mouse/human mammary stem/
myoepithelial cells, luminal progenitors or mature luminal cell dataset
from [13]. The table lists those conserved mouse/human genes
expressed by mammary stem cell (MaSC) or myoepithelial cells, luminal
progenitors (lum prog), and mature luminal (lum mature) cells found in a
previously published dataset [13] which were also found expressed by
the primordial epithelial (MBE) or mesenchymal (MM) populations in the
current study. The human stromal signature defined in [55] was used to
determine which genes were also found in the primordial epithelial or
mesenchymal populations.
Additional file 15: Gene set enrichment analysis of mammary
primordial gene expression data. This file contains the gene sets (with
a nominal P-value of < 0.05 in order of significance) enriched in
primordial cells and postnatal cells when the two data sets were
compared. Gene sets with similarity to progenitor populations are in
italics and underlined. Gene sets with a FDR q value of < 0.50 are in
bold.
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